Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Repositori Institucional UIB
Publication Artículo científico (JournalArticle)

GDF15 and ACE2 stratify COVID-19 patients according to severity while ACE2 mutations increase infection susceptibility

  • Barcelo, Carles
  • Gonzalez-Freire, Marta
  • Torrens-Mas, Margalida
  • Perelló-Reus, Catalina M
  • Trias-Ferrer, Neus
  • Ibargüen-González, Lesly
  • Crespí, Catalina
  • Galmes-Panades, Aina Maria
  • Navas-Enamorado, Cayetano
  • Sanchez-Polo, Andres
  • Piérola-Lopetegui, Javier
  • Masmiquel, Luis
  • Socias Crespi, Lorenzo
[eng] Coronavirus disease 19 (COVID-19) is a persistent global pandemic with a very heterogeneous disease presentation ranging from a mild disease to dismal prognosis. Early detection of sensitivity and severity of COVID-19 is essential for the development of new treatments. In the present study, we measured the levels of circulating growth differentiation factor 15 (GDF15) and angiotensin-converting enzyme 2 (ACE2) in plasma of severity-stratified COVID-19 patients and uninfected control patients and characterized the <em>in vitro</em> effects and cohort frequency of ACE2 SNPs. Our results show that while circulating GDF15 and ACE2 stratify COVID-19 patients according to disease severity, ACE2 missense SNPs constitute a risk factor linked to infection susceptibility.